News
The watch is also equipped with a VO2 Max indicator, a mountain bike feature and a training guidance.
Community by Current Health is now enrolling participants in a COVID-19 study that uses its FDA-cleared remote monitoring system.
Synapse Medicine will roll-out the adverse drugs monitoring technology to increase the safety of the vaccination programme.
The solution uses AI and machine learning to improve adherence.
The fund will be zeroing in on sensing tech, data analytics, remote patient monitoring and population health.
Also: docdok.health rolling out COVID-19 vaccination study app; IBM Watson Health partners with Humana.
Also: Insightin Health scores $12M for its engagement platform and Rhino Health raises $5M in seed funding for AI tech.
The device reportedly will include a cellular connection and could tie in with third-party health and wellness services, such as those offered by Peloton.
The back-to-work tool builds upon Masimo's SafetyNet remote monitoring system that was developed to help hospitals care for patients in non-traditional settings.
MobiHealthNews spoke with Pear Therapeutics, Click Therapeutics and DTx newcomer Mahana Therapeutics to discuss whether in-licensing is the way to go for those just entering the space.